Latest filing published 19 Sept 2022 for ExpreS2ion Biotech Holding AB (EXPRS2), €4,452.
Insider track record
No signal scores available.
Mattis Flyvholm Ranthe: trading record in brief
Mattis Flyvholm Ranthe discloses dealings in ExpreS2ion Biotech Holding AB (EXPRS2) to Finansinspektionen. Over a trading history stretching from 17 May 2022 to 19 September 2022, the count stands at 2 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 19 September 2022, the filings show a transaction worth €4,452 in ExpreS2ion Biotech Holding AB (EXPRS2). This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Companies and markets linked to Mattis Flyvholm Ranthe
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ SEK 4.8182.3% of flowAktieISIN SE0008348262FI:csv-300a222f7443f369c90a
- 800 shares@ SEK 12.5017.7% of flowBTA (betald tecknad aktie)ISIN SE0017780687FI:csv-10c4687722e405c107be
2 of 2 declarations